Senate Judiciary committee sends several cannabis bills to ITL after debate over regulation and patient access

A majority of the Senate Judiciary Committee recommended ITL — “inexpedient to legislate” — on multiple cannabis measures after lawmakers debated the scope of legal changes and gaps in regulation.

The committee voted 3–1 to recommend ITL on HB 75, a bill to legalize adult use of cannabis for people 21 and older, after members said the proposal lacked safety rails and quality control. The committee also voted 3–1 to recommend ITL on HB 53, which would have allowed qualifying therapeutic cannabis patients and designated caregivers to cultivate plants and possess up to 8 ounces in certain circumstances. Committee members heard additional testimony and questions about a related bill that would allow alternative treatment centers (ATCs) to use some hemp-derived ingredients and nonintoxicating cannabinoids in manufactured products; debate on that measure focused on whether synthetic cannabinoids should be permitted as ingredients and how out-of-state testing and supply would be handled.

Why it matters: Committee members who supported ITL said the measures, as written, would remove necessary public-health and enforcement safeguards. Supporters of cultivation and broader access pressed that some seriously ill patients need affordable, reliable access and that home cultivation or ATC manufacturing flexibility can reduce costs and increase availability where ATCs are limited.

What the committee heard - Concerns about adult-use legalization (HB 75). The bill drew criticism from members who said it ‘‘jumped the river without putting the bridge up,’’ arguing it provided no regulatory framework for growing, testing or controlling distribution. One member who moved the ITL motion said, ‘‘no safety rails, no quality control’’ made the bill unacceptable in its current form.

- Medical-patient cultivation and possession limits (HB 53). Supporters pointed to testimony from…